Back to Rankings

PRME

Prime MedicineF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
PRME vs peer average
29/100
PRME vs. peer average (F vs. D)
Grade spread
B 2 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

AGMB is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $575.09M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAGMBAgomAb Therapeutics
PRME
Prime Medicine
AGMB
AgomAb Therapeutics
Grade
F
N/A
Momentum
11
20
Value
41
-
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Unrated

Grade position vs AGMB

PRME / AGMB
Grade Position
Below peers
PRME vs. peer average (F vs. D)
29/100
Momentum
11
AGMB
Value
41
-
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PRME
1
AGMB
AgomAb Therapeutics NV ADR
N/A
-
-
2
PROK
ProKidney Corp Class A Common
D
40/100
-1
3
ZSQR
Z Squared Inc Common
F
20/100
Even
4
MLAB
Mesa Laboratories Inc Common
B
80/100
-3
5
ALT
Altimmune Inc Common
F
20/100
Even
AGMB is the first peer returned for this comparison set.